Shire PLC (LSE:SHP) - Share price - Overview

Stock Report

Shire PLC SHP

Last Price
GBX3,461.00

Day Change
8.50|0.25%

As of 19/01/2018
17:15:00 GMT | GBX
Minimum 15 Minutes Delay.

Last Close3,452.50p
Day Range3,458.00 - 3,529.00
Mkt Cap31.44Bil
52-Wk Range3,435.50 - 5,067.00
Yield %0.54
ISINJE00B2QKY057
Volume4,325,434
P/E21.49
P/S3.16
P/CF13.53

Share Price

Total Returns 19/01/2018

 Chg (%)  
More ...
Shire PLC-11.71 
FTSE 100 TR GBP2.61
 
Financials
201420152016
More ...
Income Statement
Turnover3,664.344,199.928,442.60
Operating Profit1,033.20929.11713.32
Net Profit1,995.88876.87453.52
Reported EPS337.83147.9257.04
Balance Sheet
Current Assets3,330.061,530.296,101.64
Non Current Assets5,428.359,738.9648,149.44
Total Assets8,758.4011,269.2554,251.08
Current Liabilities1,941.522,514.486,266.57
Total Liabilities3,192.634,600.5030,823.75
Total Equity5,565.776,668.7523,427.33
Cash Flow
Operating Cash Flow2,572.911,529.641,969.71
Net Change in Cash457.76-1,861.42290.76
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20171,867.31382.82137.669.040.0724.080.70
20184,311.91434.5813.527.960.5927.180.79

Regulatory News

DateAuthor Headline
19/12/2017David Brenchley Best Performing FTSE 100 Stocks of 2017
While the FTSE 100 has lagged most major indices this year, almost 70% of its constituents have seen their share price rise
03/08/2017Alex Morozov, CFA Which UK Stocks are the Best Value in Europe?
The Morningstar Europe Stock List features the most attractively valued companies that possess sustainable competitive advantages
09/11/2016Karen Kwok Healthcare and Mining Stocks Gain On Trump Win
FTSE 100: Mining, healthcare and building stocks rallied in London this morning as news of Donald Trump's US presidency crossed the pond
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/12/2017PurchaseMs. Anne Minto3,789.501826,897.00
19/12/2017PurchaseMr. Bill Burns3,789.501806,821.00
19/12/2017PurchaseDr. David Ginsburg3,884.981505,827.00
19/12/2017PurchaseOlivier Bohuon3,789.501616,101.00

Company Profile

Shire PLC is a biotechnology company focused mainly in the research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines for patients with rare diseases and other select conditions.

Sector

Biotechnology

Market Position

19 of 1835 Companies

Index

FTSE 100 ,FTSE 350 ,S&P Europe 350 ,Eurotop 300 ,FTSE All Share

Outlook

(27/10/2017) ceo - "I continue to be highly confident in the strength and durability of our business"

Next Event 16/02/2018

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)7.9614.145.53
Div Yld (E)0.794.064.03
PEG (E)0.59-0.460.98
ROCE24.47179.53180.33
Op Mrgn17.79-8.37-126.27
EPS Grwth13.525.7922.39
Dividends
PreviousLatest
More ...
Record Date10/03/1708/09/17
Ex-Div09/03/1707/09/17
Paid25/04/1720/10/17
Amnt20.643.85

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMs. Susan Kilsby
Chief Executive OfficerDr. Flemming Ornskov
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.